CompletedNCT03730064
Brain Inflammation and NAC Treatment for Depression in Bipolarity
About this title
Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression
Read the official source — NCT03730064Researchers studied N-acetyl cysteine (NAC) to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Medication studyAges 18–60United States
Understand this study
What did researchers investigate?
Researchers studied N-acetyl cysteine (NAC) to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: November 1, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 3
- Sponsor
- Martin Lan
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT03730064
- Official title
Show the full official title
Neuroinflammation as a Novel Target to Treat Bipolar Depression: A Pilot PET Study With [11C]PBR-28 and N-Acetyl Cysteine (NAC) Antidepressant Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied N-acetyl cysteine (NAC) to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is Martin Lan.
Did this study involve medication?
Yes. The study involved medication, including N-acetyl cysteine (NAC).
Who was this study for?
Listed age limits: 18 years to 60 years.
